161 related articles for article (PubMed ID: 31966850)
1. Up-regulation of long non-coding RNA HOXA-AS2 in non-small cell lung cancer is associated with worse survival outcome.
Li Y; Jiang H
Int J Clin Exp Pathol; 2017; 10(9):9690-9696. PubMed ID: 31966850
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer.
Shi YB; Liu SL; Mou XR; Liao J; Che JP; Fei XQ; Wang AR
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1243-1249. PubMed ID: 32096154
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HOXA-AS2 promotes cell migration and invasion via upregulating IGF-2 in non-small cell lung cancer as an oncogene.
Zheng FX; Wang XQ; Zheng WX; Zhao J
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4793-4799. PubMed ID: 31210310
[TBL] [Abstract][Full Text] [Related]
5. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HOXA‑AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‑analysis.
Xiao T; Yan A; Tan L; Zhu H; Gao W
Oncol Lett; 2024 May; 27(5):226. PubMed ID: 38586205
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOXA-AS2 Promotes Tumor Progression by Suppressing miR-567 Expression in Oral Squamous Cell Carcinoma.
Chen R; Wang X; Zhou S; Zeng Z
Cancer Manag Res; 2021; 13():5443-5455. PubMed ID: 34267554
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the prognostic and clinicopathological significance of HOXA-AS2 in human cancers: a systematic review and meta-analysis.
Lu B; Liu Z; Ji X; Zhang X
Transl Cancer Res; 2023 Mar; 12(3):605-615. PubMed ID: 37033343
[TBL] [Abstract][Full Text] [Related]
9. HOXA-AS2 may predict the prognosis of solid tumors among Chinese patients: A meta-analysis and bioinformatic analysis.
Wang Q; Zhang W; Deng C; Lin S; Zhou Y
Front Oncol; 2022; 12():1030825. PubMed ID: 36387249
[TBL] [Abstract][Full Text] [Related]
10. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis.
Jiang L; Wu Z; Meng X; Chu X; Huang H; Xu C
Hum Gene Ther; 2019 May; 30(5):618-631. PubMed ID: 30375256
[TBL] [Abstract][Full Text] [Related]
12. Microarray Analysis of Long Non-Coding RNAs in Lung Tissues of Patients with COPD and HOXA-AS2 Promotes HPMECs Proliferation via Notch1.
Zhou AY; Zhao YY; Zhou ZJ; Duan JX; Zhu YZ; Cai S; Chen P
Int J Chron Obstruct Pulmon Dis; 2020; 15():2449-2460. PubMed ID: 33116460
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer.
Wang J; Su Z; Lu S; Fu W; Liu Z; Jiang X; Tai S
Clin Chim Acta; 2018 Oct; 485():229-233. PubMed ID: 29981289
[TBL] [Abstract][Full Text] [Related]
14. HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis.
Zhang F; Zhang G; Zhang H; Pu X; Chi F; Zhang D; Xin X; Gao M; Luo W; Li X
Front Genet; 2022; 13():944278. PubMed ID: 36437956
[No Abstract] [Full Text] [Related]
15. Overexpression of HOXA-AS2 LncRNA in Patients with Gastric Cancer and Its Association with Helicobacter pylori Infection.
Rajabi A; Riahi A; Shirabadi-Arani H; Moaddab Y; Haghi M; Safaralizadeh R
J Gastrointest Cancer; 2022 Mar; 53(1):72-77. PubMed ID: 33174119
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of HOXA-AS2 suppresses proliferation and induces apoptosis in colorectal cancer.
Tong G; Wu X; Cheng B; Li L; Li X; Li Z; Nong Q; Chen X; Liu Y; Wang S
Am J Transl Res; 2017; 9(10):4545-4552. PubMed ID: 29118916
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge.
Fang Y; Wang J; Wu F; Song Y; Zhao S; Zhang Q
Oncotarget; 2017 Jul; 8(28):46090-46103. PubMed ID: 28545023
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.
Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y
Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.
Xie M; Sun M; Zhu YN; Xia R; Liu YW; Ding J; Ma HW; He XZ; Zhang ZH; Liu ZJ; Liu XH; De W
Oncotarget; 2015 Oct; 6(32):33587-601. PubMed ID: 26384350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
